Navigation Links
Powerful Anti-breast-cancer Pill on the Anvil

The US Food and Drug Administration (FDA) has granted marketing approval to pharmaceutical giant GlaxoSmithKline for its breast cancer// pill Tykerb.

It has been claimed that Tykerb is far more potent in combating advanced stages of breast cancer than the drugs currently available for the purpose.

Breast cancer is the second leading cause of cancer deaths in women worldwide. According to statistics, about a million new cases are expected to occur this year itself. Analysts reckon Tykerb could be generating 1 billion US dollars in sales by 2010. By then, it is likely to be approved for wider breast cancer indications, and other cancer types such as head and neck and renal. Further trials are underway.

Tykerb seeks to specifically target cancer-causing proteins and more effective than other new generation drugs of the genre like Herceptin.

Experts note that Herceptin has been found to have a lot of limitations, some cancers become resistant to it even. Also while Herceptin is injectible Tykerb is a pill.

Even more important, it has no side-effects, of the cardiovascular type seen in other drugs, according to Dr.K.Geeta, a surgeon attached to the Rajiv Gandhi Cancer Institute, New Delhi.

However, industry sources warn that it would be prohibitively expensive and would require governmental intervention to make it affordable for the average Indian.

Page: 1

Related medicine news :

1. Direct To Home: Television Provides Powerful Fillip to Smoking Cessation Campaigns.
2. Figment of Imagination? A Powerful US Economy Gives Rise to Fatal Heart Attacks
3. AIDS – A Powerful Mankille
4. Powerful Synergy: Botswana and Clinton foundation To Sign MOU
5. A New Study Finds Chocolate Milk Powerful Than Sports Drinks
6. Scientists Come Up With A Powerful Weapon To Fight Drug Resistant Bacteria
7. Powerful New IVF Treatment Promises Better Results
8. MEG Scanners Are Mega Powerful
9. Learning Words by Inference More Powerful for Toddlers
10. Crusade Against Cancer: Collaborations On The Anvil
11. New Drug For Oral Cancer Detection On The Anvil
Post Your Comments:

(Date:6/27/2016)... ... , ... TherapySites, the leading website and online ... Counseling Association. This new relationship allows TherapySites to continue to extend their ... benefits and promotional offers. , "TCA is extremely excited about this new partnership, ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in ... ways they remain in the eye of the beholder, according to experts who offered ... The American Journal of Managed Care. For the full issue, click here . ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
Breaking Medicine Technology: